CLHLF (Coltene Holding AG) EBIT: $23.6 Mil (TTM As of Dec. 2025)


CLHLF Coltene Holding AG CLHLF
68 GF Score
Price $61.16
GF Value $66.41
! 3 Warning Signs
View Full Analysis

What is Coltene Holding AG EBIT?

Coltene Holding AG CLHLF 68 EBIT is $23.6 Mil as of Dec. 2025. GuruFocus rates CLHLF with a GF Score™ of 68/100 and a GF Value™ of $66.41. The stock has 3 warning signs investors should review.

Coltene Holding AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was $14.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $23.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Coltene Holding AG's annualized ROC % for the quarter that ended in Dec. 2025 was 15.54%. Coltene Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 25.24%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Coltene Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.75%.

Coltene Holding AG  (OTCPK:CLHLF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Coltene Holding AG's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=33.826 * ( 1 - 16.74% )/( (183.099 + 179.283)/ 2 )
=28.1635276/181.191
=15.54 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=217.927 - 14.604 - ( 20.224 - max(0, 100.478 - 147.838+20.224))
=183.099

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=229.97 - 24.76 - ( 25.927 - max(0, 97.212 - 159.211+25.927))
=179.283

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Coltene Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=28.688/( ( (55.872 + max(23.612, 0)) + (54.885 + max(92.98, 0)) )/ 2 )
=28.688/( ( 79.484 + 147.865 )/ 2 )
=28.688/113.6745
=25.24 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(43.602 + 77.075 + 3.413) - (14.604 + 0 + 85.874)
=23.612

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(52.948 + 70.016 + 8.249) - (24.76 + 0 + 13.473)
=92.98

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Coltene Holding AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=23.6/410.769
=5.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coltene Holding AG EBIT Related Terms

Coltene Holding AG EBIT Historical Data

* Premium members only.

The historical data trend for Coltene Holding AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coltene Holding AG EBIT Chart

Coltene Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.19 35.60 19.61 30.66 23.79

Coltene Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.92 14.52 16.10 9.26 14.34

CLHLF vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Coltene Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coltene Holding AG EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Coltene Holding AG's EV-to-EBIT falls into.


CLHLF
68GF Score
Coltene Holding AG CLHLF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coltene Holding AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $23.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $23.6 Mil mean?
Coltene Holding AG (CLHLF) has a EBIT of $23.6 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Coltene Holding AG.
Is Coltene Holding AG's EBIT too high?
Coltene Holding AG's current EBIT is $23.6 Mil. Overall, Coltene Holding AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's EBIT compare to ISRG and BDX?
Coltene Holding AG's EBIT of $23.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Coltene Holding AG. Coltene Holding AG's current EBIT is $23.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Coltene Holding AG (CLHLF) has a current EBIT of $23.6 Mil. The stock's GF Value™ is $66.41, compared to a current price of $61.16 — trading 7.9% below its estimated fair value. The current EBIT is $23.6 Mil. Coltene Holding AG's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Coltene Holding AG (CLHLF), the current EBIT is $23.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coltene Holding AG (CLHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued. The current stock price of $61.16 is trading 7.9% below its estimated GF Value™ of $66.41.

Key valuation signals for CLHLF:

  • EBIT: $23.6 Mil
  • GF Value™: $66.41 vs. price of $61.16 (7.9% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the CLHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coltene Holding AG Business Description

Address Feldwiesenstrasse 20, Altstatten, CHE, 9450
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
68GF Score

Get the complete analysis for CLHLF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$61.16
Price
$66.41
GF Value